Eli Lilly stock soars after Q1 earnings as revenue grows 56% on strength of GLP-1 drug sales

Eli Lilly shares soars as sales for its GLP-1 drugs outperform.

Apr 30, 2026 - 21:00
 0  1
Eli Lilly stock soars after Q1 earnings as revenue grows 56% on strength of GLP-1 drug sales
Eli Lilly shares soars as sales for its GLP-1 drugs outperform.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow